ConductScience.org, home

Paper427004

Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

Verbeeck R and 5 others. Br J Clin Pharmacol, 1979. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency. Papers, record 427004. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/427004

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
4.45
iCite
Revised in PubMed
2019-05-09
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Verbeeck RR
2Tjandramaga TBT B
3Mullie AA
4Verbesselt RR
5Verberckmoes RR
6de Schepper PJP J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnalgesicsMajor topic
Biphenyl CompoundsMajor topic
Kidney Failure, ChronicMajor topic
Adult
Biotransformation
Creatinine
Glucuronates
Half-Life
Humans
Kinetics
Male
Renal Dialysis

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114412753Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.J Clin Invest1959https://conductscience.org/library/papers/14412753PubMed
222417Drug kinetics and artificial kidneys.Clin Pharmacokinet1977https://conductscience.org/library/papers/22417PubMed
3851117The biotransformation of drugs in renal failure.Am J Med1977https://conductscience.org/library/papers/851117PubMed
4973960The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973960PubMed
5851131Drug administration in renal failure.Am J Med1977https://conductscience.org/library/papers/851131PubMed
6328033Diflunisal: efficacy in postoperative pain.Br J Clin Pharmacol1977https://conductscience.org/library/papers/328033PubMed
74154380A guide to drug therapy in renal failure.JAMA1974https://conductscience.org/library/papers/4154380PubMed
84425338Individualization of drug dosage in patients with renal disease.Med Clin North Am1974https://conductscience.org/library/papers/4425338PubMed
91220Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.Drug Metab Dispos1975https://conductscience.org/library/papers/1220PubMed
104552824Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.Clin Pharmacol Ther1972https://conductscience.org/library/papers/4552824PubMed
111263112Pharmacokinetics of acetaminophen elimination by anephric patients.J Pharmacol Exp Ther1976https://conductscience.org/library/papers/1263112PubMed
125677334Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.J Pharm Sci1968https://conductscience.org/library/papers/5677334PubMed

Download CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
36444793Characterising diflunisal as a transthyretin kinetic stabilizer at relevant concentrations in human plasma using subunit exchange.Amyloid2023https://conductscience.org/library/papers/36444793PubMed
21234090Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.Can Fam Physician1991https://conductscience.org/library/papers/21234090PubMed
7426281Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7426281PubMed
7037261Drug metabolites in renal failure: pharmacokinetic and clinical implications.Clin Pharmacokinet1981https://conductscience.org/library/papers/7037261PubMed
6988202Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.Drugs1980https://conductscience.org/library/papers/6988202PubMed
6743473Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6743473PubMed
6723762Metabolism of amitriptyline in patients with chronic renal failure.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6723762PubMed
6352138Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet1983https://conductscience.org/library/papers/6352138PubMed
6120712Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6120712PubMed
4041343The influence of diflunisal on the pharmacokinetics of oxazepam.Br J Clin Pharmacol1985https://conductscience.org/library/papers/4041343PubMed
3729324Pharmacokinetics of carumonam in patients with renal insufficiency.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3729324PubMed
3709612Pharmacokinetics of tenoxicam in patients with impaired renal function.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3709612PubMed
3567017Pharmacokinetic profile of indoprofen in elderly subjects.Br J Clin Pharmacol1986https://conductscience.org/library/papers/3567017PubMed
3499163Effect of food and various antacids on the absorption of tenoxicam.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3499163PubMed
3402529Biliary excretion of diflunisal conjugates in patients with T-tube drainage.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/3402529PubMed
3301150Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.Clin Pharmacokinet1987https://conductscience.org/library/papers/3301150PubMed
3203058Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies.Br J Clin Pharmacol1988https://conductscience.org/library/papers/3203058PubMed
2753070Pharmacokinetic interaction between indomethacin and diflunisal.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2753070PubMed
2744070Paracetamol disposition and metabolite kinetics in patients with chronic renal failure.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2744070PubMed
2721541Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2721541PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/427004

GET https://conductscience.org/api/papers/v1/427004/cited_by?page=2